| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 151.51▼ | 151.15▼ | 151.31▼ | 154.34▼ | 148.27▲ |
| MA10 | 151.68▼ | 151.42▼ | 152.65▼ | 154.58▼ | 145.14▲ |
| MA20 | 151.45▼ | 152.79▼ | 154.43▼ | 148.92▲ | 132.22▲ |
| MA50 | 151.51▼ | 154.73▼ | 154.95▼ | 139.00▲ | 107.70▲ |
| MA100 | 153.54▼ | 155.18▼ | 151.93▼ | 130.02▲ | N/A |
| MA200 | 154.80▼ | 151.15▼ | 148.09▲ | 114.26▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.050▼ | -0.064▼ | -0.526▼ | -0.362▼ | 1.055▲ |
| RSI | 38.120▼ | 40.766▼ | 37.905▼ | 52.320▲ | 61.261▲ |
| STOCH | 44.207 | 40.199 | 29.539 | 60.694 | 79.879 |
| WILL %R | -94.783▼ | -76.818▼ | -81.655▼ | -39.928 | -17.856▲ |
| CCI | -180.579▼ | -42.703 | -78.904 | -10.076 | 75.069 |
|
Sunday, August 16, 2026 09:01 AM
Palvella Therapeutics (NASDAQ:PVLA) is advancing topical therapies for serious rare skin diseases and vascular malformations that lack FDA-approved treatments, with its lead candidate, QTORIN ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/08/26 | 152.36 | 154.56 | 149.05 | 150.42 | 144,544 |
| 17/08/26 | 154.39 | 157.65 | 152.33 | 153.52 | 187,012 |
| 14/08/26 | 156.55 | 160.33 | 154.35 | 156.13 | 105,801 |
| 13/08/26 | 156.00 | 158.76 | 150.405 | 156.55 | 240,744 |
| 12/08/26 | 157.51 | 157.99 | 152.985 | 155.07 | 165,145 |
| 11/08/26 | 154.05 | 156.78 | 152.78 | 154.30 | 188,406 |
| 10/08/26 | 156.07 | 157.9625 | 152.045 | 152.22 | 140,007 |
| 07/08/26 | 159.00 | 160.125 | 156.39 | 157.77 | 182,299 |
| 06/08/26 | 155.40 | 160.47 | 152.06 | 154.93 | 91,126 |
| 05/08/26 | 155.25 | 156.83 | 151.11 | 154.91 | 144,935 |
|
|
||||
|
|
||||
|
|